J Korean Med Sci.  2023 May;38(20):e185. 10.3346/jkms.2023.38.e185.

Immune Responses and Breakthrough Infections After COVID-19 Vaccination

• Kwon KT

• KMID: 2542596
• DOI: http://doi.org/10.3346/jkms.2023.38.e185

Reference

1. Park WB, Hwang YH, Cheong HJ. COVID-19 vaccination in Korea. Infect Chemother. 2023; 55(1):135–149. PMID: 37021429.

2. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med. 2022; 386(16):1532–1546. PMID: 35249272.

3. Kang YM, Minn D, Lim J, Lee KD, Jo DH, Choe KW, et al. Comparison of antibody response elicited by ChAdOx1 and BNT162b2 COVID-19 vaccine. J Korean Med Sci. 2021; 36(46):e311. PMID: 34845875.

4. Choi SH, Park JY, Kweon OJ, Park JH, Kim MC, Lim Y, et al. Immune responses after vaccination with primary 2-dose ChAdOx1 plus a booster of BNT162b2 or vaccination with primary 2-dose BNT162b2 plus a booster of BNT162b2 and the occurrence of omicron breakthrough infection. J Korean Med Sci. 2023; 38(20):e155.

5. Wherry EJ, Barouch DH. T cell immunity to COVID-19 vaccines. Science. 2022; 377(6608):821–822. PMID: 35981045.